HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michael Rugaard Jensen Selected Research

Michael Rugaard Jensen Research Topics

Disease

9Neoplasms (Cancer)
01/2019 - 04/2003
3Breast Neoplasms (Breast Cancer)
04/2010 - 01/2008
1B-Cell Lymphoma (Lymphoma, B Cell)
01/2017
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
06/2013
1Melanoma (Melanoma, Malignant)
04/2010
1Pathologic Constriction (Stenosis)
03/2010
1Thrombosis (Thrombus)
03/2010
1Coronary Artery Disease (Coronary Atherosclerosis)
03/2010
1Atherosclerotic Plaque (Atheroma)
03/2010
1Carcinogenesis
01/2008

Drug/Important Bio-Agent (IBA)

7Proteins (Proteins, Gene)FDA Link
01/2017 - 07/2006
2Pharmaceutical PreparationsIBA
11/2015 - 01/2008
2Heat-Shock Proteins (Heat-Shock Protein)IBA
06/2013 - 01/2008
25- (2,4- dihydroxy- 5- isopropylphenyl)- 4- (4- morpholin- 4- ylmethylphenyl)isoxazole- 3- carboxylic acid ethylamideIBA
06/2013 - 01/2008
2Molecular Chaperones (Chaperone, Molecular)IBA
11/2012 - 08/2009
1Tumor Suppressor Protein p14ARF (p14ARF)IBA
01/2017
1Proto-Oncogene Proteins c-mdm2IBA
01/2017
1Tumor Suppressor Protein p53IBA
01/2017
1siremadlinIBA
01/2017
1ErbB Receptors (EGF Receptor)IBA
06/2013
1Tyrosine Kinase InhibitorsIBA
06/2013
1Biological ProductsIBA
06/2013
1NVP-BEP800IBA
04/2010
1Oxygen (Dioxygen)IBA
03/2010
1Biomarkers (Surrogate Marker)IBA
02/2010
1Diethylnitrosamine (N-Nitrosodiethylamine)IBA
04/2003
1CyclinsIBA
04/2003
1Cyclin G1IBA
04/2003

Therapy/Procedure

4Therapeutics
01/2019 - 03/2010
1Oral Administration
04/2010
1Stents
03/2010
1Drug-Eluting Stents
03/2010
1Aftercare (After-Treatment)
04/2003